DalsnaFinance › IPOs › Caris Life Sciences › IPO
Caris Life Sciences, Inc. completed its initial public offering on NASDAQ on June 18, 2025, pricing at $21.00 a share.
| Ticker | CAI |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 18, 2025 |
| Offering price | $21.00 |
| Shares offered | 23,529,412 |
| Total raised | $494M |
Caris Life Sciences, Inc. sold 23,529,412 shares at $21.00 each on NASDAQ. Multiplied out, that is $494.1 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $494 million total recorded for the deal.
Measured by money raised, Caris Life Sciences, Inc. was the 47th largest of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million, so this one was about 2.5 times the typical size.
Among the 342 listings on NASDAQ alone, it is the 24th largest.
June 2025 saw 24 completed IPOs in the site's data; by amount raised, Caris Life Sciences, Inc. was the 3rd largest of the 24 deals with a recorded size.
Its $21.00 offer price was tied for the 53rd highest (level with 8 other listings) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
Caris Life Sciences, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Caris Life Sciences, Inc.. This page is general information, not investment advice.